Skip to main navigation Skip to search Skip to main content

Pathway to effective treatment for common mental and substance use disorders in the World Mental Health Surveys: Perceived need for treatment

  • Meredith G. Harris
  • , Alan E. Kazdin
  • , Irving Hwang
  • , Sophie M. Manoukian
  • , Nancy A. Sampson
  • , Dan J. Stein
  • , Maria Carmen Viana
  • , Daniel V. Vigo
  • , Jordi Alonso
  • , Laura Helena Andrade
  • , Ronny Bruffaerts
  • , Brendan Bunting
  • , José Miguel Caldas-de-Almeida
  • , Stephanie Chardoul
  • , Giovanni de Girolamo
  • , Oye Gureje
  • , Josep Maria Haro
  • , Elie G. Karam
  • , Viviane Kovess-Masfety
  • , Maria Elena Medina-Mora
  • Fernando Navarro-Mateu, Daisuke Nishi, José Posada-Villa, Charlene Rapsey, Juan Carlos Stagnaro, Margreet ten Have, Jacek Wciórka, Zahari Zarkov, Ronald C. Kessler

Research output: Contribution to journal › Article › peer-review

13 Downloads (Pure)

Abstract

Background: Perceived need for treatment is a first step along the pathway to effective mental health treatment. Perceived need encompasses a person’s recognition that they have a problem and their belief that professional help is needed to manage the problem. These two components could have different predictors.

Methods: Respondents aged 18+ years with 12-month mental disorders from 25 representative household surveys in 21 countries in the World Mental Health Survey Initiative (n = 12,508). All surveys included questions about perceived need; 16 surveys (13 countries) included additional questions about respondents’ main reason for perceived need—problem recognition or perceived inability to manage without professional help (n = 9814). Associations of three sets of predictors (disorder, socio-demographics, past treatment) with perceived need and its components were examined using Poisson regression models.

Results: Across the 16 surveys with additional questions, 42.4% of respondents with a 12-month mental disorder reported perceived need for treatment. In separate multivariable models for each predictor set: (1) Most disorder types (except alcohol use disorder, specific phobia), disorder severity, and number of disorders were associated with perceived need and both of its components; (2) Sociodemographic factors tended to differentially predict either problem recognition (females, 30–59 years, disabled/unemployed) or need for professional help (females, homemakers, disabled/unemployed, public insurance); (3) Past treatment factors (type of professional, psychotherapy, helpful or unhelpful treatment) were associated with perceived need and both components, except number of past professionals differentially predicted problem recognition. In a consolidated model: employment and insurance became non-significant; type and number of past professionals seen became more important; helpful past treatment predicted greater need for professional help while unhelpful treatment predicted lower problem recognition. Problem recognition was the more important component in determining perceived need for some groups (e.g., severe disorder, people who consulted non-mental health professionals).

Conclusions: Greater clinical need is a key determinant of perceived need for treatment. Findings suggest a need for strategies to address low perceived need (e.g., in males, older people, alcohol use disorders) and lower endorsement of professional treatment in some groups, and to improve patient’s treatment experiences which are important enablers of future help-seeking.
Original languageEnglish
Article number17
Pages (from-to)1-17
Number of pages17
JournalInternational Journal of Mental Health Systems
Volume19
Issue number1
Early online date23 May 2025
DOIs
Publication statusPublished online - 23 May 2025

Bibliographical note

Publisher Copyright:
© The Author(s) 2025.

Data Availability Statement

Access to the cross-national World Mental Health (WMH) data is governed by the organizations funding and responsible for survey data collection in each country. These organizations made data available to the WMH consortium through restricted data sharing agreements that do not allow us to release the data to third parties. The exception is that the U.S. data are available for secondary analysis via the Inter-University Consortium for Political and Social Research (ICPSR), http://www.icpsr.umich.edu/icpsrweb/ICPSR/series/00527.

Funding

The World Health Organization World Mental Health (WMH) Survey Initiative is supported by the United States National Institute of Mental Health (NIMH; R01 MH070884), the John D. and Catherine T. MacArthur Foundation, the Pfzer Foundation, the United States Public Health Service (R13-MH066849, R01-MH069864, and R01 DA016558), the Fogarty International Center (FIRCA R03-TW006481), the Pan American Health Organization, Eli Lilly and Company, Ortho-McNeil Pharmaceutical Inc., GlaxoSmithKline, and Bristol-Myers Squibb. We thank the staf of the WMH Data Collection and Data Analysis Coordina‑ tion Centres for assistance with instrumentation, feldwork, and consultation on data analysis. The Argentina survey−Estudio Argentino de Epidemiología en Salud Mental (EASM)−was supported by a grant from the Argentinian Ministry of Health (Ministerio de Salud de la Nación)−(Grant Number 2002-17270/13-5). The São Paulo Megacity Mental Health Survey is supported by the State of São Paulo Research Foundation (FAPESP) Thematic Project Grant 03/00204-3. The Bulgarian Epidemiological Study of common mental disorders -EPIBUL—is supported by the Ministry of Health and the National Center for Public Health Protection. EPIBUL 2, conducted in 2016–17, is supported by the Ministry of Health and European Economic Area Grants. The Colombian National Study of Mental Health (NSMH) is supported by the Ministry of Social Protection. The Mental Health Study Medellín – Colombia was carried out and supported jointly by the Center for Excellence on Research in Mental Health (CES Univer‑ sity) and the Secretary of Health of Medellín. The ESEMeD surveys (Belgium; France; Germany; Italy; Netherlands; Spain) were funded by the European Commission (Contracts QLG5-1999-01042; SANCO 2004123, and EAHC 20081308), the Piedmont Region [Italy]), Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, Spain (FIS 00/0028), Ministerio de Ciencia y Tecnología, Spain (SAF 2000-158-CE), Generalitat de Catalunya (2017 SGR 452; 2014 SGR 748), Instituto de Salud Carlos III (CIBER CB06/02/0046, RETICS RD06/0011 REM-TAP), and other local agencies and by an unrestricted educational grant from GlaxoSmithKline. The Israel National Health Survey is funded by the Ministry of Health with support from the Israel National Institute for Health Policy and Health Services Research and the National Insurance Institute of Israel. The World Mental Health Japan (WMHJ) Survey is supported by the Grant for Research on Psychiatric and Neurological Diseases and Mental Health (H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013, H25-SEISHINIPPAN-006) from the Japan Ministry of Health, Labour and Welfare. The Lebanese Evaluation of the Burden of Ailments and Needs of the Nation (L.E.B.A.N.O.N.) is supported by the Lebanese Ministry of Public Health, the WHO (Lebanon), National Institute of Health / Fogarty International Center (R03 TW006481-01), anonymous private donations to IDRAAC, Lebanon, and unrestricted grants from, Algorithm, AstraZeneca, Benta, Bella Pharma, Eli Lilly, Glaxo Smith Kline, Lundbeck, Novartis, OmniPharma, Pfzer, Phenicia, Servier, UPO. The Mexican National Comorbidity Survey (MNCS) is supported by the National Institute of Psychiatry Ramon de la Fuente (INPRFMDIES 4280) and by the National Council on Science and Technology (CONACyT-G30544-H), with supplemental support from the Pan American Health Organization (PAHO). The Nigerian Survey of Mental Health and Wellbeing (NSMHW) is supported by the World Health Organization (WHO) (Geneva), the WHO (Nigeria), and the Federal Ministry of Health, Abuja, Nigeria. The Northern Ireland Study of Mental Health was funded by the Health & Social Care Research & Development Division of the Public Health Agency. The Peruvian World Mental Health Study was funded by the National Institute of Health of the Ministry of Health of Peru. The Polish project Epidemiology of Mental Health and Access to Care –EZOP Project (PL 0256) was carried out by the Institute of Psychiatry and Neurol‑ ogy, Warsaw in consortium with the Department of Psychiatry, Medical University, Wroclaw, the National Institute of Public Health—National Institute of Hygiene, Warsaw and in partnership with Psykiatrist Institut, Vinderen, Universitet Oslo. The project was funded by the European Economic Area Financial Mechanism and the Norwegian Financial Mechanism. EZOP project was co-fnanced by the Polish Ministry of Health. The second Polish survey, EZOP – 2, was carried out by the Institute of Psychiatry and Neurology, Warsaw in collaboration with colleagues from the National Institute of Public Health – National Institute of Hygiene, Warsaw and was entirely funded by the Polish Ministry of Health. The Portuguese Mental Health Study was carried out by the Department of Mental Health, Faculty of Medical Sciences, NOVA University of Lisbon, with collaboration of the Portuguese Catholic University, and was funded by Champalimaud Foundation, Gulbenkian Foundation, Foundation for Science and Technology (FCT) and the Portuguese Ministry of Health. The Romania WMH study projects "Policies in Mental Health Area" and "National Study regarding Mental Health and Services Use" were carried out by National School of Public Health & Health Services Management (present National School of Public Health Management & Professional Development, Bucharest), with technical support of Metro Media Transilvania, the National Institute of Statistics, SC Cheyenne Services SRL, and Statistics Netherlands. Funding was provided by the Ministry of Public Health with supplemental support of Eli Lilly Romania SRL. The Psychiatric Enquiry to General Population in Southeast Spain – Murcia (PEGASUS-Murcia) Project has been fnanced by the Regional Health Authori‑ ties of Murcia (Servicio Murciano de Salud and Consejería de Sanidad y Política Social) and Fundación para la Formación e Investigación Sanitarias (FFIS) of Murcia. The US National Comorbidity Survey Replication (NCS-R) is supported by the National Institute of Mental Health (NIMH; U01-MH60220) with supplemental support from the National Institute of Drug Abuse (NIDA), the Substance Abuse and Mental Health Services Administration (SAMHSA), the Robert Wood Johnson Foundation (RWJF; Grant 044708), and the John W. Alden Trust. Dr. Dan J. Stein is supported by the Medical Research Council of South Africa (MRC). None of the funders had any role in the design, analysis, interpretation of results, or preparation of this paper. The views and opinions expressed in this report are those of the authors and should not be construed to represent the views of the sponsoring organizations, agencies, or governments. A complete list of all within-country and cross-national WMH publications can be found at http://www.hcp.med.harvard.edu/wmh/

FundersFunder number
National Institute of Drug Abuse
Public Health Agency
National Institute of Public Health
Institute of Psychiatry and Neurology, Warszawa
World Health Organization
GlaxoSmithKline
Ministry of Health
Generalitat de Catalunya2014 SGR 748, RETICS RD06/0011 REM-TAP, 2017 SGR 452, CB06/02/0046
Instituto de Salud Carlos IIIFIS 00/0028
03/00204-3
SAF 2000-158-CE
R03 TW006481-01
National Institute of Mental HealthU01-MH60220
2002-17270/13-5
European CommissionQLG5-1999-01042, SANCO 2004123, EAHC 20081308
044708
4280

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • Mental health services
    • Substance use disorders
    • Mental disorders
    • Health professionals
    • Treatment history
    • Perceived need for treatment
    • Perceived helpfulness

    Fingerprint

    Dive into the research topics of 'Pathway to effective treatment for common mental and substance use disorders in the World Mental Health Surveys: Perceived need for treatment'. Together they form a unique fingerprint.

    Cite this